ArticleResearch and practice in thrombosis and haemostasis2019

Extending recombinant factor IX Fc fusion protein dosing interval to 14 or more days in patients with hemophilia B.

Amy D Shapiro et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.